• 25 years of experience
  • PhD in Pathobiology
  • Doctor of Medicine from University of California, San Francisco
  • Interned at USC’s Department of Surgery
  • Director of Surgical Neuro-oncology at USC
  • American Board of Neurological Surgery Certification
  • Congress of Neurological Surgeons Member
  • American Association of Neurological Surgery Member
  • American Association of Cancer Research Member
  • North American Spine Society Member
  • Society of Neuro-Oncology Member
  • American Society of Clinical Oncology Member
  • Southern California Super Doctors recipient from Los Angeles Magazine
  • Top Doctor recipient from Castle Connolly
  • Voted one of the Best Doctors in 2008
  • Voted one of America’s Top Surgeons in 2007
  • Voted one of America’s Top Oncologists (Neuro-oncology) in 2007
  • Associate Editor: Spine Journal, Journal of Neuro-Oncology

Dr. Thomas Chen, MD, PhD

Board Member

Dr. Thomas Chen is a physician, a board-certified neurosurgeon, and the Director of Surgical Neuro-oncology at USC. He is also a tenured Professor of Neurosurgery and Pathology at USC. Dr. Chen graduated summa cum laude in three years from the University of Illinois at Urbana-Champaign, where he received Bronze Tablet honors (top 3% of undergraduate students) and was inducted into the Phi Beta Kappa national academic honor society. He attended the University of California, San Francisco, where he was inducted into the Alpha Omega Alpha national medical honor society. After graduation Dr. Chen underwent neurosurgery training at the University of Southern California. In order to prepare for his career in neuro-oncology, Dr. Chen obtained his PhD degree in pathobiology from the University of California, San Francisco. His thesis was on the role of immunotherapy in malignant brain tumors. He is a fellowship-trained spine surgeon and one of a few surgical neuro-oncologists in the country who specialize in spine cancer surgery.

Currently, Dr. Chen maintains a clinical practice in both surgical neuro-oncology and spine surgery. He heads a research laboratory focused on glioma biology at USC and  is involved in developing new and novel treatments for the treatment of brain and spinal tumor disease. This includes include anti-EGFRviii vaccine therapy, IL-4-pseudomonas exotoxin for convection-enhanced delivery, and anti-tenascin brachytherapy. He is also co-developing surgical therapies is based on the newest techniques in microdissection and image guidance using neuronavigational therapy,

Dr. Chen is a member of several professional societies including the Congress of Neurological Surgeons, the American Association of Neurological Surgery, and the American Association of Cancer Research as well as several others. He is the recipient of many awards and peer recognition including being named one of Southern California Super Doctors by Los Angeles Magazine in 2015, one of America’s Top Surgeons in 2007 and one of America’s Top Oncologists (for Neuro-Oncology) in 2007.

Dr. Chen has published extensively on glioma biology and neurosurgery. He is on the editorial board for The Spine Journal and Journal of Neuro-oncology, and is on the review board for Neurosurgery and Journal of Neurosurgery. Dr. Chen also serves on numerous national neurosurgery committees.